Register to gain access to personalised information regarding Brand, the indications your are treating regularly, dosing guidelines and resources such as Major Studies, Patient Information and short videos curated to your special interest.

Resources

MAJOR STUDIES

Explore the data that helped Xarelto to become the most broadly indicated novel OAC in the world1.

XARELTO TUBE

Short videos and interactive Tools to illustrate the science behind thrombotic events and the benefits of Xarelto.

INFORMATION FOR PATIENTS

A suite of downloads to help patients understand their treatment with Xarelto.

USEFUL WEBSITES

A selection of websites to support responsible anticoagulant use for your patients’ benefit.

PP-XAR-ALL-1811-1

References

Xarelto^® (rivaroxaban) Summary of Product Characteristics as approved by the European Commission. Xarelto^® (rivaroxaban) Summary of Product Characteristics as approved by the European Commission. Return to content

DOSING GUIDE

PRACTICAL MANAGEMENT

PRESCRIBING INFORMATION

Resources

MAJOR STUDIES

XARELTO TUBE

INFORMATION FOR PATIENTS

USEFUL WEBSITES

References

If you would prefer to visit your local website, please select your country:

DOSING GUIDE

PRACTICAL MANAGEMENT

PRESCRIBING INFORMATION

Resources

MAJOR STUDIES

XARELTO TUBE

INFORMATION FOR PATIENTS

USEFUL WEBSITES

References